Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
Witthaus H, Kaufmann C, Bohner G, Ozgürdal S, Gudlowski Y, Gallinat J, Ruhrmann S, Brüne M, Heinz A, Klingebiel R, et al. Psychiatry Res. 2009 Sep 30; 173(3):163-9. Epub 2009 Jul 17.